Brian Carrico
President and CEO of NeurAxis, a growth-stage medtech company focused on neuromodulation therapies for chronic gastrointestinal disorders; led the company through FDA de novo clearance, multiple clinical studies, and achieving a Category I CPT code and payer coverage milestones.
Best podcasts with Brian Carrico
Ranked by the Snipd community
Mar 2, 2026 • 60min
NeurAxis, Inc. (NRXS): Growth-Stage Medtech
Brian Carrico, President and CEO of NeurAxis, leads a growth-stage medtech company developing neuromodulation therapies for chronic gastrointestinal disorders. He discusses the impact of a Category I CPT code and payer coverage milestones. Conversation covers pediatric focus, VA market entry, clinical trial plans, scaling operations, and reimbursement strategy.
